Molnupiravir
|
- $35 - $46000
- Product name: Molnupiravir
- CAS: 2349386-89-4
- MF: C13H19N3O7
- MW: 329.31
- EINECS:604-604-1
- MDL Number:
- Synonyms:EIDD-2801(EIDD 2801);Uridine, 4-oxime, 5'-(2-methylpropanoate);β-D-N4 hydroxycytidine-5'-isopropyl ester;MolnupiravirEIDD-2801(API);UNII-YA84KI1VEW;EIDD-2801(Molnupiravir);((2R,3S,4R,5R)-3,4-dihydroxy-5-(4-(hydroxyamino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate;EIDO-2801
13 prices
Selected condition：
Brand
- Adipogen Life Sciences
- AK Scientific
- Ambeed
- Cayman Chemical
- Chemenu
- DC Chemicals
- Sigma-Aldrich
Package
- 1mg
- 5mg
- 10mg
- 25mg
- 007
- 50mg
- 100mg
- 500g
- ManufacturerAdipogen Life Sciences
- Product numberAG-CR1-3733-M050
- Product descriptionEIDD-2801 ≥98%(HPLC)
- Packaging50mg
- Price$150
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number1772EP
- Product descriptionEIDD-2801
- Packaging100mg
- Price$522
- Updated2021-12-16
- Buy
- ManufacturerAmbeed
- Product numberA1241514
- Product description((2R,3S,4R,5R)-3,4-Dihydroxy-5-(4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methylisobutyrate 98%
- Packaging1mg
- Price$190
- Updated2021-12-16
- Buy
- ManufacturerAmbeed
- Product numberA1241514
- Product description((2R,3S,4R,5R)-3,4-Dihydroxy-5-(4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methylisobutyrate 98%
- Packaging5mg
- Price$320
- Updated2021-12-16
- Buy
- ManufacturerAmbeed
- Product numberA1241514
- Product description((2R,3S,4R,5R)-3,4-Dihydroxy-5-(4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methylisobutyrate 98%
- Packaging10mg
- Price$540
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number29586
- Product descriptionEIDD-2801
- Packaging1mg
- Price$35
- Updated2023-06-20
- Buy
- ManufacturerCayman Chemical
- Product number29586
- Product descriptionEIDD-2801
- Packaging5mg
- Price$85
- Updated2023-06-20
- Buy
- ManufacturerCayman Chemical
- Product number29586
- Product descriptionEIDD-2801
- Packaging10mg
- Price$151
- Updated2023-06-20
- Buy
- ManufacturerCayman Chemical
- Product number29586
- Product descriptionEIDD-2801
- Packaging25mg
- Price$293
- Updated2023-06-20
- Buy
- ManufacturerChemenu
- Product numberCM330019
- Product description((2R,3S,4R,5R)-3,4-dihydroxy-5-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methylisobutyrate 95%+
- Packaging500g
- Price$46000
- Updated2021-12-16
- Buy
- ManufacturerDC Chemicals
- Product number012096
- Product descriptionEIDD-2801(Molnupiravir)
- Packaging007
- Price$3500
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberSML2873
- Product descriptionEIDD-2801 ≥98% (HPLC)
- Packaging5MG
- Price$94.2
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product numberSML2873
- Product descriptionEIDD-2801 ≥98% (HPLC)
- Packaging25MG
- Price$381
- Updated2024-03-01
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Adipogen Life Sciences | AG-CR1-3733-M050 | EIDD-2801 ≥98%(HPLC) | 50mg | $150 | 2021-12-16 | Buy |
| AK Scientific | 1772EP | EIDD-2801 | 100mg | $522 | 2021-12-16 | Buy |
| Ambeed | A1241514 | ((2R,3S,4R,5R)-3,4-Dihydroxy-5-(4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methylisobutyrate 98% | 1mg | $190 | 2021-12-16 | Buy |
| Ambeed | A1241514 | ((2R,3S,4R,5R)-3,4-Dihydroxy-5-(4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methylisobutyrate 98% | 5mg | $320 | 2021-12-16 | Buy |
| Ambeed | A1241514 | ((2R,3S,4R,5R)-3,4-Dihydroxy-5-(4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methylisobutyrate 98% | 10mg | $540 | 2021-12-16 | Buy |
| Cayman Chemical | 29586 | EIDD-2801 | 1mg | $35 | 2023-06-20 | Buy |
| Cayman Chemical | 29586 | EIDD-2801 | 5mg | $85 | 2023-06-20 | Buy |
| Cayman Chemical | 29586 | EIDD-2801 | 10mg | $151 | 2023-06-20 | Buy |
| Cayman Chemical | 29586 | EIDD-2801 | 25mg | $293 | 2023-06-20 | Buy |
| Chemenu | CM330019 | ((2R,3S,4R,5R)-3,4-dihydroxy-5-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methylisobutyrate 95%+ | 500g | $46000 | 2021-12-16 | Buy |
| DC Chemicals | 012096 | EIDD-2801(Molnupiravir) | 007 | $3500 | 2021-12-16 | Buy |
| Sigma-Aldrich | SML2873 | EIDD-2801 ≥98% (HPLC) | 5MG | $94.2 | 2024-03-01 | Buy |
| Sigma-Aldrich | SML2873 | EIDD-2801 ≥98% (HPLC) | 25MG | $381 | 2024-03-01 | Buy |
Properties
Melting point :156 - 159°C
storage temp. :-20°C, Inert atmosphere
solubility :DMSO (Slightly), Methanol (Slightly)
form :Solid
color :White to Off-White
InChI :InChI=1/C13H19N3O7/c1-6(2)12(19)22-5-7-9(17)10(18)11(23-7)16-4-3-8(15-21)14-13(16)20/h3-4,6-7,9-11,17-18,21H,5H2,1-2H3,(H,14,15,20)/t7-,9-,10-,11-/s3
InChIKey :HTNPEHXGEKVIHG-JFPRWSRANA-N
SMILES :O[C@@H]1[C@@H]([C@@H](COC(=O)C(C)C)O[C@H]1N1C=C/C(=N/O)/NC1=O)O |&1:1,2,3,12,r|
storage temp. :-20°C, Inert atmosphere
solubility :DMSO (Slightly), Methanol (Slightly)
form :Solid
color :White to Off-White
InChI :InChI=1/C13H19N3O7/c1-6(2)12(19)22-5-7-9(17)10(18)11(23-7)16-4-3-8(15-21)14-13(16)20/h3-4,6-7,9-11,17-18,21H,5H2,1-2H3,(H,14,15,20)/t7-,9-,10-,11-/s3
InChIKey :HTNPEHXGEKVIHG-JFPRWSRANA-N
SMILES :O[C@@H]1[C@@H]([C@@H](COC(=O)C(C)C)O[C@H]1N1C=C/C(=N/O)/NC1=O)O |&1:1,2,3,12,r|
Safety Information
| Symbol(GHS): |
|
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Danger | ||||||||||||||
| Hazard statements: |
|
||||||||||||||
| Precautionary statements: |
|
Description
EIDD-2801 is an orally bioavailable prodrug of the antiviral nucleoside derivative N4- hydroxycytidine (NHC, EIDD-1931). It is a nucleotide analog inhibitor of RNA-dependent RNA polymerases (RdRps). The compound interferes with the action of viral RNA polymerase. It exerts its antiviral action through introduction of copying errors during viral RNA replication. The active drug incorporates into the genome of RNA viruses, leading to an accumulation of mutations known as viral error catastrophe. The broadspectrum antiviral agent EIDD-2801 inhibits viral RNA replication in various unrelated RNA viruses including influenza, Ebola, Venezuelan equine encephalitis virus (VEEV) and coronaviruses, including SARS-CoV, MERS-CoV and SARS-CoV-2. EIDD-2801 has the potential for COVID-19, seasonal and pandemic influenza treatment.Suppliers and manufacturers
weifang runzhong fine chemical co., ltd
ATK CHEMICAL COMPANY LIMITED
Shenzhen Nexconn Pharmatechs Ltd
ENBRIDGE PHARMTECH CO., LTD.
